Biogen
BIIB
#581
Rank
$32.14 B
Marketcap
$221.11
Share price
0.87%
Change (1 day)
-18.69%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - P/B ratio

P/B ratio as of February 2024 : 2.22

According to Biogen's latest financial reports the company has a price-to-book ratio of 2.22.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Biogen - P/B ratio (from 2004 to 2022)

P/B ratio by year

Year P/B ratio Change
2022-12-312.98-7.38%
2021-12-313.22-8.8%
2020-12-313.53-9.01%
2019-12-313.88-14.9%
2018-12-314.55-14.85%
2017-12-315.355.12%
2016-12-315.09-28.78%
2015-12-317.14-2.98%
2014-12-317.36-3.93%
2013-12-317.6654.13%
2012-12-314.9719.55%
2011-12-314.1640.54%
2010-12-312.9626.03%
2009-12-312.35-0.62%
2008-12-312.36-22.3%
2007-12-313.0431.12%
2006-12-312.324.22%
2005-12-312.23-32.87%
2004-12-313.32
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.37 141.75%๐Ÿ‡บ๐Ÿ‡ธ USA
1.61-27.59%๐Ÿ‡บ๐Ÿ‡ธ USA
25.5 1,048.53%๐Ÿ‡บ๐Ÿ‡ธ USA
19.8 793.91%๐Ÿ‡บ๐Ÿ‡ธ USA
1.51-31.85%๐Ÿ‡ซ๐Ÿ‡ท France
4.10 84.75%๐Ÿ‡บ๐Ÿ‡ธ USA
3.68 65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2976-86.59%๐Ÿ‡บ๐Ÿ‡ธ USA
2.57 15.73%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
1.15-48.06%๐Ÿ‡บ๐Ÿ‡ธ USA